Inventor
OPHIR ERAN
IL15 patents
⚠️ This page may combine multiple inventors who share the name “OPHIR ERAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
COMPUGEN LTD
7 patentsUS10751415B2Aug 25, 2020
Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof
COMPUGEN LTD6 citations83
US10213505B2Feb 26, 2019
Anti-TIGIT anibodies, anti-PVRIG antibodies and combinations thereof
COMPUGEN LTD6 citations83
US10124061B2Nov 13, 2018
Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof
COMPUGEN LTD9 citations83
US11701424B2Jul 18, 2023
Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof
COMPUGEN LTD1 citations72
US11225523B2Jan 18, 2022
Triple combination antibody therapies
COMPUGEN LTD3 citations68
US12558421B2Feb 24, 2026
Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof
COMPUGEN LTD0 citations61
US12152084B2Nov 26, 2024
Triple combination antibody therapies
COMPUGEN LTD0 citations57
YEDA RES & DEV
6 patentsUS11179448B2Nov 23, 2021
Genetically modified anti-third party central memory T cells and use of same in immunotherapy
YEDA RES & DEV5 citations82
US10933124B2Mar 2, 2021
Methods of transplantation and disease treatment
YEDA RES & DEV4 citations82
US12508307B2Dec 30, 2025
Genetically modified anti-third party central memory T cells and use of same in immunotherapy
YEDA RES & DEV1 citations73
US11844827B2Dec 19, 2023
Genetically modified anti-third party central memory T cells and use of same in immunotherapy
YEDA RES & DEV1 citations71
US12133866B2Nov 5, 2024
Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
YEDA RES & DEV0 citations60
US11324777B2May 10, 2022
Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
YEDA RES & DEV1 citations60
REISNER YAIR
2 patentsUS9738872B2Aug 22, 2017
Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
REISNER YAIR12 citations82
US9421228B2Aug 23, 2016
Use of anti third party central memory T cells for anti-leukemia/lymphoma treatment
REISNER YAIR12 citations80